BIOMAT Database Logo BIOMAT Database Logo

Measures of frequency: calculating prevalence and incidence in the era of COVID-19. 2020

Marcia Margaret Menezes Pizzichini, and Cecilia Maria Patino, and Juliana Carvalho Ferreira
. Methods in Epidemiologic, Clinical, and Operations Research-MECOR-program, American Thoracic Society/Asociación Latinoamericana del Tórax, Montevideo, Uruguay.

UI MeSH Term Description Entries
D011024 Pneumonia, Viral Inflammation of the lung parenchyma that is caused by a viral infection. Pneumonias, Viral,Viral Pneumonia,Viral Pneumonias
D001938 Brazil A country located on the eastern coast of South America, located between Colombia and Peru, that borders the Atlantic Ocean. It is bordered on the north by Venezuela, Guyana, Suriname, and French Guiana, on the south by Uruguay, and on the west by Argentina. The capital is Brasilia.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000073640 Betacoronavirus A genus of the family CORONAVIRIDAE which causes respiratory or gastrointestinal disease in a variety of mostly mammals. Human betacoronaviruses include HUMAN ENTERIC CORONAVIRUS; HUMAN CORONAVIRUS OC43; MERS VIRUS; and SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS. Members have either core transcription regulatory sequences of 5’-CUAAAC-3’ or 5’-CUAAAC-3’ and mostly have no ORF downstream to the N protein gene. HCoV-HKU1,Human coronavirus HKU1,Pipistrellus bat coronavirus HKU5,Rousettus bat coronavirus HKU9,Tylonycteris bat coronavirus HKU4,Betacoronaviruses
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity
D015991 Epidemiologic Measurements Statistical calculations on the occurrence of disease or other health-related conditions in defined populations. Measurements, Epidemiologic,Epidemiologic Measurement,Measurement, Epidemiologic
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

Marcia Margaret Menezes Pizzichini, and Cecilia Maria Patino, and Juliana Carvalho Ferreira
Measures of disease frequency: prevalence and incidence.
January 2010, Nephron. Clinical practice,
Marcia Margaret Menezes Pizzichini, and Cecilia Maria Patino, and Juliana Carvalho Ferreira
[Measures of frequency in epidemiology studies: incidence and prevalence].
January 2010, Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia,
Marcia Margaret Menezes Pizzichini, and Cecilia Maria Patino, and Juliana Carvalho Ferreira
Incidence and prevalence as measures of the frequency of birth defects.
November 1982, American journal of epidemiology,
Marcia Margaret Menezes Pizzichini, and Cecilia Maria Patino, and Juliana Carvalho Ferreira
National TB prevalence surveys in the COVID-19 era.
January 2022, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
Marcia Margaret Menezes Pizzichini, and Cecilia Maria Patino, and Juliana Carvalho Ferreira
Re: "Incidence and prevalence as measures of the frequency of birth defects".
October 1983, American journal of epidemiology,
Marcia Margaret Menezes Pizzichini, and Cecilia Maria Patino, and Juliana Carvalho Ferreira
Re: "Incidence and prevalence as measures of the frequency of birth defects".
January 1984, American journal of epidemiology,
Marcia Margaret Menezes Pizzichini, and Cecilia Maria Patino, and Juliana Carvalho Ferreira
Influenza incidence overlapped with COVID-19 or under COVID-19 control measures.
August 2022, Immunity, inflammation and disease,
Marcia Margaret Menezes Pizzichini, and Cecilia Maria Patino, and Juliana Carvalho Ferreira
[Prevalence measures and the incidence-prevalence ratio].
July 1995, Medicina clinica,
Marcia Margaret Menezes Pizzichini, and Cecilia Maria Patino, and Juliana Carvalho Ferreira
COVID-19 containment measures and incidence of invasive bacterial disease.
June 2021, The Lancet. Digital health,
Marcia Margaret Menezes Pizzichini, and Cecilia Maria Patino, and Juliana Carvalho Ferreira
Prevalence and determinants of Italian physicians' burnout in the "post-COVID-19" era.
April 2023, International archives of occupational and environmental health,
Copied contents to your clipboard!